These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30073858)

  • 41. On the use of caffeine as a contrast booster for BOLD fMRI studies.
    Mulderink TA; Gitelman DR; Mesulam MM; Parrish TB
    Neuroimage; 2002 Jan; 15(1):37-44. PubMed ID: 11771972
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Resolving the transition from negative to positive blood oxygen level-dependent responses in the developing brain.
    Kozberg MG; Chen BR; DeLeo SE; Bouchard MB; Hillman EM
    Proc Natl Acad Sci U S A; 2013 Mar; 110(11):4380-5. PubMed ID: 23426630
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of blood oxygenation and cerebral blood flow effects in fMRI: estimation of relative oxygen consumption change.
    Kim SG; Uğurbil K
    Magn Reson Med; 1997 Jul; 38(1):59-65. PubMed ID: 9211380
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vascular component analysis of hyperoxic and hypercapnic BOLD contrast.
    Schwarzbauer C; Deichmann R
    Neuroimage; 2012 Feb; 59(3):2401-12. PubMed ID: 21945792
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Brain region and activity-dependent properties of M for calibrated fMRI.
    Shu CY; Herman P; Coman D; Sanganahalli BG; Wang H; Juchem C; Rothman DL; de Graaf RA; Hyder F
    Neuroimage; 2016 Jan; 125():848-856. PubMed ID: 26529646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A three-dimensional single-scan approach for the measurement of changes in cerebral blood volume, blood flow, and blood oxygenation-weighted signals during functional stimulation.
    Cheng Y; Qin Q; van Zijl PCM; Pekar JJ; Hua J
    Neuroimage; 2017 Feb; 147():976-984. PubMed ID: 28041979
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Calibrated fMRI for dynamic mapping of CMRO
    Englund EK; Fernández-Seara MA; Rodríguez-Soto AE; Lee H; Rodgers ZB; Vidorreta M; Detre JA; Wehrli FW
    J Cereb Blood Flow Metab; 2020 Jul; 40(7):1501-1516. PubMed ID: 31394960
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mapping oxidative metabolism in the human brain with calibrated fMRI in health and disease.
    Chen JJ; Uthayakumar B; Hyder F
    J Cereb Blood Flow Metab; 2022 Jul; 42(7):1139-1162. PubMed ID: 35296177
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative BOLD: mapping of human cerebral deoxygenated blood volume and oxygen extraction fraction: default state.
    He X; Yablonskiy DA
    Magn Reson Med; 2007 Jan; 57(1):115-26. PubMed ID: 17191227
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Negative blood oxygen level dependence in the rat: a model for investigating the role of suppression in neurovascular coupling.
    Boorman L; Kennerley AJ; Johnston D; Jones M; Zheng Y; Redgrave P; Berwick J
    J Neurosci; 2010 Mar; 30(12):4285-94. PubMed ID: 20335464
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stimulus-dependent BOLD and perfusion dynamics in human V1.
    Hoge RD; Atkinson J; Gill B; Crelier GR; Marrett S; Pike GB
    Neuroimage; 1999 Jun; 9(6 Pt 1):573-85. PubMed ID: 10334901
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blood oxygenation level-dependent (BOLD)-based techniques for the quantification of brain hemodynamic and metabolic properties - theoretical models and experimental approaches.
    Yablonskiy DA; Sukstanskii AL; He X
    NMR Biomed; 2013 Aug; 26(8):963-86. PubMed ID: 22927123
    [TBL] [Abstract][Full Text] [Related]  

  • 53. On the nature of the BOLD fMRI contrast mechanism.
    Logothetis NK; Pfeuffer J
    Magn Reson Imaging; 2004 Dec; 22(10):1517-31. PubMed ID: 15707801
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mapping of cerebral metabolic rate of oxygen using DSC and BOLD MR imaging: a preliminary study.
    Shiino A; Yamauchi H; Morikawa S; Inubushi T
    Magn Reson Med Sci; 2012; 11(2):109-15. PubMed ID: 22790297
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is optical imaging spectroscopy a viable measurement technique for the investigation of the negative BOLD phenomenon? A concurrent optical imaging spectroscopy and fMRI study at high field (7 T).
    Kennerley AJ; Mayhew JE; Boorman L; Zheng Y; Berwick J
    Neuroimage; 2012 May; 61(1):10-20. PubMed ID: 22440642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cerebrovascular reactivity measured with arterial spin labeling and blood oxygen level dependent techniques.
    Zhou Y; Rodgers ZB; Kuo AH
    Magn Reson Imaging; 2015 Jun; 33(5):566-76. PubMed ID: 25708263
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-BOLD contrast for laminar fMRI in humans: CBF, CBV, and CMR
    Huber L; Uludağ K; Möller HE
    Neuroimage; 2019 Aug; 197():742-760. PubMed ID: 28736310
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Large enhancement of perfusion contribution on fMRI signal.
    Wang X; Zhu XH; Zhang Y; Chen W
    J Cereb Blood Flow Metab; 2012 May; 32(5):907-18. PubMed ID: 22395206
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Spatial nonuniformity of the resting CBF and BOLD responses to sevoflurane: in vivo study of normal human subjects with magnetic resonance imaging.
    Qiu M; Ramani R; Swetye M; Constable RT
    Hum Brain Mapp; 2008 Dec; 29(12):1390-9. PubMed ID: 17948882
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative assessment of the reproducibility of functional activation measured with BOLD and MR perfusion imaging: implications for clinical trial design.
    Tjandra T; Brooks JC; Figueiredo P; Wise R; Matthews PM; Tracey I
    Neuroimage; 2005 Aug; 27(2):393-401. PubMed ID: 15921936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.